Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway

Zhang,Zhang; Rui,Wei; Wang,Zi-Chen; Liu,Da-Xin; Du,Lin

doi:10.3892/or.2017.5760

Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway

Authors:
- Zhang Zhang
- Wei Rui
- Zi-Chen Wang
- Da-Xin Liu
- Lin Du
View Affiliations

Affiliations: Department of Acupuncture and Moxibustion, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, P.R. China, Department of Supply, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, P.R. China, Department of Traditional Chinese Medicine, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, P.R. China
Published online on: June 27, 2017 https://doi.org/10.3892/or.2017.5760
Pages: 1172-1180

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non-small cell lung carcinoma (NSCLC) is the most common lung cancer with high morbidity and mortality. The traditional treatment for NSCLC is particularly liable to relapse with many side-effects. Barbaloin is a natural compound with anticancer efficacy. The present study aimed to investigate the anticancer potential of barbaloin in NSCLC. The results displayed that barbaloin inhibited the viability of A549 cells by decreasing cell growth and the expression level of Ki-67 and proliferating cell nuclear antigen (PCNA), especially at high concentrations (50 and 100 µM). Besides, barbaloin increased the apoptosis rate of A549 cells and induced an accumulation of G2/M phase. Increased expression of apoptosis-related proteins (caspase-3, -8 and -9) and the changed levels of cell cycle checkpoint proteins (p27, p53 and cyclin A) further convinced of the anti-viability effect of barbaloin in A549 cells. On the other hand, barbaloin significantly suppressed the invasion and migration of A549 cells, and restrained the expression of tumor metastasis-related proteins. We further explored the activation of pro-survival or pro-metastasis signaling pathways, including AKT, nuclear factor kappa B (NF-κB), mitogen-actived protein kinase (MAPK) and β-catenin. The results revealed that barbaloin inactivated the p38MAPK/Cdc25B/Hsp27 pathway by inhibiting p38 nucleus translocation, while no significant influence was observed among other pathways. Finally, barbaloin restrained the growth and hepatic metastases of A549 cells in vivo. Taken together, our research indicated that barbaloin inhibited the proliferation and metastasis of NSCLC cells in vivo and in vitro. This may provide safer and more effective aspects for the treatment of NSCLC.

View Figures

View References

1	Zhang BY, Wang YM, Gong H, Zhao H, Lv XY, Yuan GH and Han SR: Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC). Int J Clin Exp Pathol. 8:25–37. 2015.PubMed/NCBI
2	Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L and Kunkler I: EUROCARE-4 Working Group: Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
3	DArcangelo M and Hirsch FR: Clinical and comparative utility of afatinib in non-small cell lung cancer. Biologics. 8:183–192. 2014.PubMed/NCBI
4	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
5	Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, Watanabe H, Wu YL, Zielinski M, Ball D and Rami-Porta R: International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions: The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 10:1675–1684. 2015. View Article : Google Scholar : PubMed/NCBI
6	Avelino CU, Cardoso RM, Aguiar SS and Silva MJ: Assessment of quality of life in patients with advanced non-small cell lung carcinoma treated with a combination of carboplatin and paclitaxel. J Bras Pneumol. 41:133–142. 2015. View Article : Google Scholar : PubMed/NCBI
7	Waller DA: Neoadjuvant chemotherapy in non small cell lung cancer-the UK experience. Lung Cancer. 34:(Suppl 3). S31–S33. 2001. View Article : Google Scholar : PubMed/NCBI
8	Azim HA Jr and Ganti AK: Treatment options for relapsed small-cell lung cancer. Anticancer Drugs. 18:255–261. 2007. View Article : Google Scholar : PubMed/NCBI
9	Tabolacci C, Rossi S, Lentini A, Provenzano B, Turcano L, Facchiano F and Beninati S: Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation. Amino Acids. 44:293–300. 2013. View Article : Google Scholar : PubMed/NCBI
10	Pan Q, Pan H, Lou H, Xu Y and Tian L: Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo. Cancer Cell Int. 13:692013. View Article : Google Scholar : PubMed/NCBI
11	Esmat AY, Tomasetto C and Rio MC: Cytotoxicity of a natural anthraquinone (Aloin) against human breast cancer cell lines with and without ErbB-2: Topoisomerase IIalpha coamplification. Cancer Biol Ther. 5:97–103. 2006. View Article : Google Scholar : PubMed/NCBI
12	Esmat AY, El-Gerzawy SM and Rafaat A: DNA ploidy and S phase fraction of breast and ovarian tumor cells treated with a natural anthracycline analog (aloin). Cancer Biol Ther. 4:108–112. 2005. View Article : Google Scholar : PubMed/NCBI
13	Nićiforović A, Adzić M, Spasić SD and Radojcić MB: Antitumor effects of a natural anthracycline analog (Aloin) involve altered activity of antioxidant enzymes in HeLaS3 cells. Cancer Biol Ther. 6:1200–1205. 2007. View Article : Google Scholar : PubMed/NCBI
14	He ZH, Huang YQ, Weng SF, Tan YR, He TP, Qin YM and Liang NC: Effect of Aloe emodin on invasion and metastasis of high metastatic breast cancer MDA-MB-231 cells. Zhong Yao Cai. 36:1481–1485. 2013.(In Chinese). PubMed/NCBI
15	He TP, Yan WH, Mo LE and Liang NC: Inhibitory effect of aloe-emodin on metastasis potential in HO-8910PM cell line. J Asian Nat Prod Res. 10:383–390. 2008. View Article : Google Scholar : PubMed/NCBI
16	Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, Kang SE, Tang CH, Ko JL and Chen SS: Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol Carcinog. 49:783–797. 2010.PubMed/NCBI
17	Yeh FT, Wu CH and Lee HZ: Signaling pathway for aloe-emodin-induced apoptosis in human H460 lung nonsmall carcinoma cell. Int J Cancer. 106:26–33. 2003. View Article : Google Scholar : PubMed/NCBI
18	He H, Zheng L, Sun YP, Zhang GW and Yue ZG: Steroidal saponins from Paris polyphylla suppress adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMP-2 and MMP-9. Asian Pac J Cancer Prev. 15:10911–10916. 2014. View Article : Google Scholar : PubMed/NCBI
19	Mou H, Zheng Y, Zhao P, Bao H, Fang W and Xu N: Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. Toxicol In Vitro. 25:1027–1032. 2011. View Article : Google Scholar : PubMed/NCBI
20	Fei F, Li X, Xu L, Li D, Zhang Z, Guo X, Yang H, Chen Z and Xing J: CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway. Ann Surg Oncol. 21:4359–4368. 2014. View Article : Google Scholar : PubMed/NCBI
21	Gastonguay A, Berg T, Hauser AD, Schuld N, Lorimer E and Williams CL: The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biol Ther. 13:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
22	Chien ST, Lin SS, Wang CK, Lee YB, Chen KS, Fong Y and Shih YW: Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38α MAPK signaling pathway. Mol Cell Biochem. 350:135–148. 2011. View Article : Google Scholar : PubMed/NCBI
23	Miao Y, Wang L, Zhang X, Xu X, Jiang G, Fan C, Liu Y, Lin X, Yu J, Zhang Y, et al: Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. PLoS One. 9:e1122582014. View Article : Google Scholar : PubMed/NCBI
24	McGuire S: World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr. 7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
25	Zhang J, Chen SF, Zhen Y, Xiang J, Wu C, Bao P, Luketich J, Hu H, Zhou X, Zhang J, et al: Multicenter analysis of lung cancer patients younger than 45 years in Shanghai. Cancer. 116:3656–3662. 2010. View Article : Google Scholar : PubMed/NCBI
26	Min J, Huang K, Tang H, Ding X, Qi C, Qin X and Xu Z: Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways. Oncol Rep. 34:2871–2879. 2015.PubMed/NCBI
27	Tan C, Qian X, Jia R, Wu M and Liang Z: Matrine induction of reactive oxygen species activates p38 leading to caspase-dependent cell apoptosis in non-small cell lung cancer cells. Oncol Rep. 30:2529–2535. 2013.PubMed/NCBI
28	Lissoni P, Rovelli F, Brivio F, Zago R, Colciago M, Messina G, Mora A and Porro G: A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer. In Vivo. 23:171–175. 2009.PubMed/NCBI
29	Ismail S, Haris K, Ghani Abdul AR, Abdullah JM, Johan MF and Yusoff Mohamed AA: Enhanced induction of cell cycle arrest and apoptosis via the mitochondrial membrane potential disruption in human U87 malignant glioma cells by aloe emodin. J Asian Nat Prod Res. 15:1003–1012. 2013. View Article : Google Scholar : PubMed/NCBI
30	Yang M, Li L, Heo SM and Soh Y: Aloe-emodin induces chondrogenic differentiation of ATDC5 cells via MAP kinases and BMP-2 signaling pathways. Biomol Ther (Seoul). 24:395–401. 2016. View Article : Google Scholar : PubMed/NCBI
31	Liu K, Park C, Li S, Lee KW, Liu H, He L, Soung NK, Ahn JS, Bode AM, Dong Z, et al: Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2. Carcinogenesis. 33:1406–1411. 2012. View Article : Google Scholar : PubMed/NCBI
32	Ma JW, Hung CM, Lin YC, Ho CT, Kao JY and Way TD: Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells. Oncotarget. 7:58915–58930. 2016.PubMed/NCBI
33	Tabolacci C, Lentini A, Mattioli P, Provenzano B, Oliverio S, Carlomosti F and Beninati S: Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells. Life Sci. 87:316–324. 2010. View Article : Google Scholar : PubMed/NCBI